Loading
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Latest filing published 09 Jun 2026 for Axsome Therapeutics, Inc..
Filing timeline
BuySaleNick Pizzie
Insider track record
Disclosed buys
3
Disclosed sells
1
Signal history
Closed purchases
Market purchases
3
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +53.6%Entry US$36.59 · Close at T+365 US$56.22
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Nick Pizzie: trading record in brief
Nick Pizzie (finance chief) discloses dealings in Axsome Therapeutics, Inc. to SEC (Form 4). Between 26 September 2019 and 9 June 2026, the trades on record add up to 7 filings.
Both buying and selling appear: 3 purchases worth €119k, against 1 sale worth €6.9M. Taken together, the sales exceed the purchases by €6.7M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 3 option exercises. Since January 2026: no purchases and 1 sale on the market.
The median purchase comes to €49k.
The newest entry dates from 9 June 2026: an option exercise, in Axsome Therapeutics, Inc. The clock since the last published purchase (22 November 2021) now reads 1,797 days. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Nick Pizzie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
33,000 sharesCommon StockSEC:0001193125-26-264035:0
33,000 shares@ US$240.0949.7% of flowCommon StockSEC:0001193125-26-264035:1
12,000 shares@ US$3.500.5% of flowCommon StockSEC:0001193125-26-021378:0
12,000 shares@ US$3.500.6% of flowCommon StockSEC:0000950170-25-021716:0
527 shares@ US$35.500.2% of flowCommon StockSEC:0001209191-21-066005:0
Canonical exit: 16 Feb 2022 (T+90)
777 shares@ US$76.64Common StockSEC:0001104659-20-078440:0
Canonical exit: 27 Sept 2020 (T+90)
2,180 shares@ US$24.80Common StockSEC:0001104659-19-051908:0
Canonical exit: 25 Dec 2019 (T+90)
7 of 7 declarations
